Literature DB >> 14749092

Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients.

Linda E Carlson1, Michael Speca, Kamala D Patel, Eileen Goodey.   

Abstract

OBJECTIVES: This study investigated the relationships between a mindfulness-based stress reduction meditation program for early stage breast and prostate cancer patients and quality of life, mood states, stress symptoms, and levels of cortisol, dehydroepiandrosterone-sulfate (DHEAS) and melatonin.
METHODS: Fifty-nine patients with breast cancer and 10 with prostate cancer enrolled in an eight-week Mindfulness-Based Stress Reduction (MBSR) program that incorporated relaxation, meditation, gentle yoga, and daily home practice. Demographic and health behavior variables, quality of life, mood, stress, and the hormone measures of salivary cortisol (assessed three times/day), plasma DHEAS, and salivary melatonin were assessed pre- and post-intervention.
RESULTS: Fifty-eight and 42 patients were assessed pre- and post-intervention, respectively. Significant improvements were seen in overall quality of life, symptoms of stress, and sleep quality, but these improvements were not significantly correlated with the degree of program attendance or minutes of home practice. No significant improvements were seen in mood disturbance. Improvements in quality of life were associated with decreases in afternoon cortisol levels, but not with morning or evening levels. Changes in stress symptoms or mood were not related to changes in hormone levels. Approximately 40% of the sample demonstrated abnormal cortisol secretion patterns both pre- and post-intervention, but within that group patterns shifted from "inverted-V-shaped" patterns towards more "V-shaped" patterns of secretion. No overall changes in DHEAS or melatonin were found, but nonsignificant shifts in DHEAS patterns were consistent with healthier profiles for both men and women.
CONCLUSIONS: MBSR program enrollment was associated with enhanced quality of life and decreased stress symptoms in breast and prostate cancer patients, and resulted in possibly beneficial changes in hypothalamic-pituitary-adrenal (HPA) axis functioning. These pilot data represent a preliminary investigation of the relationships between MBSR program participation and hormone levels, highlighting the need for better-controlled studies in this area.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749092     DOI: 10.1016/s0306-4530(03)00054-4

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  145 in total

1.  Enhanced psychosocial well-being following participation in a mindfulness-based stress reduction program is associated with increased natural killer cell activity.

Authors:  Carolyn Y Fang; Diane K Reibel; Margaret L Longacre; Steven Rosenzweig; Donald E Campbell; Steven D Douglas
Journal:  J Altern Complement Med       Date:  2010-05       Impact factor: 2.579

2.  Mindfulness, Education, and Exercise for age-related cognitive decline: Study protocol, pilot study results, and description of the baseline sample.

Authors:  Julie Loebach Wetherell; Hayley S Ripperger; Michelle Voegtle; Beau M Ances; David Balota; Emily S Bower; Colin Depp; Lisa Eyler; Erin R Foster; Denise Head; Tamara Hershey; Steven Hickman; Noralinda Kamantigue; Samuel Klein; J Philip Miller; Michael D Yingling; Jeanne Nichols; Ginger E Nicol; Bruce W Patterson; Thomas L Rodebaugh; Joshua S Shimony; Abraham Snyder; Mary Stephens; Susan Tate; Mary L Uhrich; David Wing; Gregory F Wu; Eric J Lenze
Journal:  Clin Trials       Date:  2020-06-27       Impact factor: 2.486

3.  Effectiveness of a physical activity and weight loss intervention for middle-aged women: healthy bodies, healthy hearts randomized trial.

Authors:  Molly B Conroy; Kathleen L Sward; Kathleen C Spadaro; Dana Tudorascu; Irina Karpov; Bobby L Jones; Andrea M Kriska; Wishwa N Kapoor
Journal:  J Gen Intern Med       Date:  2014-11-13       Impact factor: 5.128

4.  Adolescents' cortisol reactivity and subjective distress in response to family conflict: the moderating role of internalizing symptoms.

Authors:  Lauren A Spies; Gayla Margolin; Elizabeth J Susman; Elana B Gordis
Journal:  J Adolesc Health       Date:  2011-06-02       Impact factor: 5.012

5.  A randomized study of the effects of mindfulness training on psychological well-being and symptoms of stress in patients treated for cancer at 6-month follow-up.

Authors:  Richard Bränström; Pia Kvillemo; Judith Tedlie Moskowitz
Journal:  Int J Behav Med       Date:  2012-12

6.  Couples coping with multiple sclerosis: a dyadic perspective on the roles of mindfulness and acceptance.

Authors:  Kenneth I Pakenham; Christina Samios
Journal:  J Behav Med       Date:  2012-06-12

7.  Association of stress management skills and perceived stress with physical and emotional well-being among advanced prostrate cancer survivors following androgen deprivation treatment.

Authors:  Frank J Penedo; Catherine Benedict; Eric S Zhou; Mikal Rasheed; Lara Traeger; Bruce R Kava; Mark Soloway; Sara Czaja; Michael H Antoni
Journal:  J Clin Psychol Med Settings       Date:  2013-03

8.  Spiritual well-being, cortisol, and suicidality in Croatian war veterans suffering from PTSD.

Authors:  Sanea Mihaljević; Bjanka Vuksan-Ćusa; Darko Marčinko; Elvira Koić; Zorana Kušević; Miro Jakovljević
Journal:  J Relig Health       Date:  2011-06

9.  A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation.

Authors:  Melissa A Rosenkranz; Richard J Davidson; Donal G Maccoon; John F Sheridan; Ned H Kalin; Antoine Lutz
Journal:  Brain Behav Immun       Date:  2012-10-22       Impact factor: 7.217

10.  Diurnal saliva cortisol levels and relations to psychosocial factors in a population sample of middle-aged Swedish men and women.

Authors:  Elaine Sjögren; Per Leanderson; Margareta Kristenson
Journal:  Int J Behav Med       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.